Chu Rennes Hopital Pontchaillou — Rennes

Public research footprint of Chu Rennes Hopital Pontchaillou, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Extensive Stage Small Cell Lung Cancer (ES-SCLC) · Multiple Myeloma · Non-ischemic Ventricular Tachycardia · Leukemia, Myeloid, Acute

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT06635824 — Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of… (Active Not Recruiting)
NCT07210723 — A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Chu Rennes Hopital Pontchaillou?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.